BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 17336738)

  • 1. Value of insulin-like growth factor system markers in the assessment of growth hormone status.
    Clemmons DR
    Endocrinol Metab Clin North Am; 2007 Mar; 36(1):109-29. PubMed ID: 17336738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical utility of measurements of insulin-like growth factor 1.
    Clemmons DR
    Nat Clin Pract Endocrinol Metab; 2006 Aug; 2(8):436-46. PubMed ID: 16932333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess.
    Wiesli P; Zwimpfer C; Zapf J; Schmid C
    Acta Obstet Gynecol Scand; 2006; 85(8):900-5. PubMed ID: 16862465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and growth hormone (GH) therapy in children with GH deficiency: experience in King Chulalongkorn Memorial Hospital, Thailand.
    Wacharasindhu S; Supornsilchai V; Aroonparkmongkol S; Srivuthana S
    J Med Assoc Thai; 2007 Oct; 90(10):2047-52. PubMed ID: 18041422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total and free insulin-like growth factor I, insulin-like growth factor binding protein 3 and acid-labile subunit reflect clinical activity in acromegaly.
    Sneppen SB; Lange M; Pedersen LM; Kristensen L LØ; Main KM; Juul A; Skakkebaek NE; Feldt-Rasmussen U
    Growth Horm IGF Res; 2001 Dec; 11(6):384-91. PubMed ID: 11914026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acromegaly and insulin-like growth factors].
    Zapf J; Froesch ER
    Schweiz Med Wochenschr; 1986 Jan; 116(3):71-7. PubMed ID: 3945791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is further evaluation for growth hormone (GH) deficiency necessary in fibromyalgia patients with low serum insulin-like growth factor (IGF)-I levels?
    Yuen KC; Bennett RM; Hryciw CA; Cook MB; Rhoads SA; Cook DM
    Growth Horm IGF Res; 2007 Feb; 17(1):82-8. PubMed ID: 17289417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polysomnographic sleep, growth hormone insulin-like growth factor-I axis, leptin, and weight loss.
    Rasmussen MH; Wildschiødtz G; Juul A; Hilsted J
    Obesity (Silver Spring); 2008 Jul; 16(7):1516-21. PubMed ID: 18464752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical markers of acromegaly: GH vs. IGF-I.
    Barkan AL
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S97-100. PubMed ID: 15135787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Somatomedins (author's transl)].
    Binoux M
    Sem Hop; 1981 May 8-15; 57(17-18):923-8. PubMed ID: 6165086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of growth hormone (GH) and insulin-like growth factor (IGF) system in ovarian folliculogenesis.
    Silva JR; Figueiredo JR; van den Hurk R
    Theriogenology; 2009 May; 71(8):1193-208. PubMed ID: 19193432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of insulin-like growth factor II by a specific radioreceptor assay in serum of normal individuals, patients with abnormal growth hormone secretion, and patients with tumor-associated hypoglycemia.
    Daughaday WH; Trivedi B; Kapadia M
    J Clin Endocrinol Metab; 1981 Aug; 53(2):289-94. PubMed ID: 7019228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved screening for growth hormone deficiency using logical analysis data.
    Lemaire P; Brauner N; Hammer P; Trivin C; Souberbielle JC; Brauner R
    Med Sci Monit; 2009 Jan; 15(1):MT5-10. PubMed ID: 19114977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current diagnostic guidelines for biochemical diagnosis of acromegaly.
    Ferone D; Resmini E; Bocca L; Giusti M; Barreca A; Minuto F
    Minerva Endocrinol; 2004 Dec; 29(4):207-23. PubMed ID: 15765030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of ER-alpha polymorphisms and the intrafollicular IGF system for predicting pregnancy in IVF-ET patients.
    Choi YS; Kim SH; Ku SY; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY
    Gynecol Obstet Invest; 2009; 67(2):73-80. PubMed ID: 18843190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indications, limitations and pitfalls in the determination of human growth hormone, IGF-I and their binding proteins.
    Laron Z; Bidlingmaier M; Strasburger CJ
    Pediatr Endocrinol Rev; 2007 Oct; 5 Suppl 1():555-69. PubMed ID: 18167466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of weight loss on free insulin-like growth factor-I in obese women with hyposomatotropism.
    Rasmussen MH; Juul A; Hilsted J
    Obesity (Silver Spring); 2007 Apr; 15(4):879-86. PubMed ID: 17426323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PPAR-gamma activator rosiglitazone fails to lower plasma growth hormone and insulin-like growth factor-1 levels in patients with acromegaly.
    Bastemir M; Akin F; Yaylali GF
    Neuroendocrinology; 2007; 86(2):119-23. PubMed ID: 17671378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factors and binding proteins in early milk from mothers of preterm and term infants.
    Elmlinger MW; Hochhaus F; Loui A; Frommer KW; Obladen M; Ranke MB
    Horm Res; 2007; 68(3):124-31. PubMed ID: 17341887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Laboratory diagnosis of growth hormone].
    Macchia V; Mariano A
    Minerva Endocrinol; 1993 Sep; 18(3 Suppl 1):36-42. PubMed ID: 7910655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.